PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 8811329-2 1996 The combination of flow cytometry and 3-color immunofluorescence revealed a remarkable increase in the absolute numbers of CD5+ B cells in hyperthyroid-untreated GD patients (218 +/- 137 x 10(6)/l vs. 66 +/- 69 x 10(6)/l in healthy subjects, p < 0.01) that gradually fell to normal values once hyperthyroidism had been controlled by methimazole. Methimazole 336-347 CD5 molecule Homo sapiens 123-126 9825565-0 1998 Methimazole treatment in Graves" disease: behaviour of CD5+B lymphocytes and regulatory T cell subsets. Methimazole 0-11 CD5 molecule Homo sapiens 55-58 8958783-10 1996 These results show that, in vivo, GD patients treated with methimazole exhibited an abnormal but rather stable pattern of B cell distribution, similar to that present in hyperthyroid untreated GD patients, except for the CD5+ and CD5- B cell populations. Methimazole 59-70 CD5 molecule Homo sapiens 221-224 8958783-10 1996 These results show that, in vivo, GD patients treated with methimazole exhibited an abnormal but rather stable pattern of B cell distribution, similar to that present in hyperthyroid untreated GD patients, except for the CD5+ and CD5- B cell populations. Methimazole 59-70 CD5 molecule Homo sapiens 230-233